Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Hospital |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 3/27/2019 |
| Start Date: | February 6, 2019 |
| End Date: | February 2020 |
This study seeks to test standard and behavioral economic-enhanced training strategies to
bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among
Emergency Department providers.
bolster first-time Emergency Department-initiated buprenorphine-naloxone administration among
Emergency Department providers.
Philadelphia is experiencing a significant opioid crisis. Through this novel pilot study,
critical training about opioid use disorder and medication-assisted treatment with
buprenorphine-naloxone will be provided to emergency providers and changes in clinical
practice will be incentivized in order to optimize treatment engagement for patients with
opioid use disorder in the Emergency Department.
Participants will be invited to participate in a brief in-person training session, will
receive a pre- and post-session knowledge and attitude assessment, and will be invited to
self-report first-time buprenorphine-naloxone Emergency Department administration within the
3 month study period.
Participants will be randomized to one of two arms: standard training arm and behavioral
economic enhanced arm. The standard training arm will receive the aforementioned
intervention. The behavioral economic enhanced arm will additionally receive an opt-out
invitation, loss-framed incentivization, and weekly tailored text message-based reminders.
Endpoints of interest include retained knowledge and change in provider attitudes regarding
Emergency department buprenorphine-naloxone administration and treatment following training
and again at 3 months, and first-time Emergency department administration of
buprenorphine-naloxone.
critical training about opioid use disorder and medication-assisted treatment with
buprenorphine-naloxone will be provided to emergency providers and changes in clinical
practice will be incentivized in order to optimize treatment engagement for patients with
opioid use disorder in the Emergency Department.
Participants will be invited to participate in a brief in-person training session, will
receive a pre- and post-session knowledge and attitude assessment, and will be invited to
self-report first-time buprenorphine-naloxone Emergency Department administration within the
3 month study period.
Participants will be randomized to one of two arms: standard training arm and behavioral
economic enhanced arm. The standard training arm will receive the aforementioned
intervention. The behavioral economic enhanced arm will additionally receive an opt-out
invitation, loss-framed incentivization, and weekly tailored text message-based reminders.
Endpoints of interest include retained knowledge and change in provider attitudes regarding
Emergency department buprenorphine-naloxone administration and treatment following training
and again at 3 months, and first-time Emergency department administration of
buprenorphine-naloxone.
Inclusion Criteria:
- Residents and Advanced Practice Providers and attending clinicians working in
emergency departments in Pennsylvania.
Exclusion Criteria:
We found this trial at
1
site
Click here to add this to my saved trials
